VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
Chubb Limited vs Pfizer Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Chubb Limited
CB · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Chubb Limited's moat claims, evidence, and risks.
View CB analysisPfizer Inc.
PFE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Chubb Limited leads (68 / 100 vs 58 / 100 for Pfizer Inc.).
- Segment focus: Chubb Limited has 6 segments (40% in North America Commercial P&C Insurance); Pfizer Inc. has 5 segments (47.4% in Primary Care).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Chubb Limited has 6 moat types across 4 domains; Pfizer Inc. has 8 across 3.
Primary market context
Chubb Limited
North America Commercial P&C Insurance
Commercial property & casualty and corporate accident & health insurance
North America
Businesses and institutions (middle market to large corporates); specialty commercial
Primary insurer / underwriter
40%
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
47.4%
Side-by-side metrics
Moat coverage
Shared moat types
Chubb Limited strengths
Pfizer Inc. strengths
Segment mix
Chubb Limited segments
Full profile >North America Commercial P&C Insurance
Competitive
North America Personal P&C Insurance
Oligopoly
North America Agricultural Insurance
Oligopoly
Overseas General Insurance
Competitive
Global Reinsurance
Oligopoly
Life Insurance
Competitive
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Pfizer CentreOne
Competitive
Pfizer Ignite
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.